CA2497333A1 - Derives de pyrazole utilises en tant qu'inhibiteurs de la transcriptase inverse - Google Patents
Derives de pyrazole utilises en tant qu'inhibiteurs de la transcriptase inverse Download PDFInfo
- Publication number
- CA2497333A1 CA2497333A1 CA002497333A CA2497333A CA2497333A1 CA 2497333 A1 CA2497333 A1 CA 2497333A1 CA 002497333 A CA002497333 A CA 002497333A CA 2497333 A CA2497333 A CA 2497333A CA 2497333 A1 CA2497333 A1 CA 2497333A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- formula
- cycloalkyl
- compound
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention concerne des dérivés de pyrazole représentés par la formule (I) ou des sels, des solvates, ou des dérivés pharmaceutiquement acceptables de ceux-ci; dans la formule, R' à R4 sont tels que définis dans la description. Cette invention concerne également des procédés de préparation, des produits intermédiaires utilisés lors de la préparation de ces dérivés de pyrazole, des compositions les contenant ainsi que les utilisations de tels dérivés. Les composés décrits dans cette invention se fixent à la transcriptase inverse, et sont des modulateurs, plus spécifiquement des inhibiteurs. Ces composés sont utilisés pour le traitement de divers troubles, y compris ceux impliquant l'inhibition de la transcriptase inverse. Entre autres troubles concernés, figurent ceux causés par le virus de l'immunodéficience humaine (VIH) et des rétrovirus génétiquement associés, tels que le syndrome d'immunodéficience acquise (SIDA).
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0222374A GB0222374D0 (en) | 2002-09-26 | 2002-09-26 | Chemical compounds |
GB0222374.1 | 2002-09-26 | ||
GB0223356A GB0223356D0 (en) | 2002-10-08 | 2002-10-08 | Chemical compounds |
GB0223356.7 | 2002-10-08 | ||
PCT/IB2003/004158 WO2004029042A1 (fr) | 2002-09-26 | 2003-09-15 | Derives de pyrazole utilises en tant qu'inhibiteurs de la transcriptase inverse |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2497333A1 true CA2497333A1 (fr) | 2004-04-08 |
Family
ID=32044462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002497333A Abandoned CA2497333A1 (fr) | 2002-09-26 | 2003-09-15 | Derives de pyrazole utilises en tant qu'inhibiteurs de la transcriptase inverse |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1546132A1 (fr) |
JP (1) | JP2006504803A (fr) |
AU (1) | AU2003260908A1 (fr) |
BR (1) | BR0314709A (fr) |
CA (1) | CA2497333A1 (fr) |
MX (1) | MXPA05003195A (fr) |
WO (1) | WO2004029042A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2057125E (pt) | 2006-08-16 | 2011-05-31 | Hoffmann La Roche | Inibidores n?o nucle?sidos de transcriptase inversa |
CN101784529A (zh) | 2007-06-22 | 2010-07-21 | 弗·哈夫曼-拉罗切有限公司 | 作为非核苷逆转录酶抑制剂的脲和氨基甲酸酯衍生物 |
WO2009080534A1 (fr) | 2007-12-21 | 2009-07-02 | F. Hoffmann-La Roche Ag | Composés hétérocycliques antiviraux |
JO3637B1 (ar) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
TW201932470A (zh) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 具有抗rsv活性之吡唑并嘧啶 |
KR20200116099A (ko) | 2018-01-31 | 2020-10-08 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Rsv에 대한 활성을 갖는 시클로알킬 치환 피라졸로피리미딘 |
MA52348A (fr) | 2018-04-23 | 2021-03-03 | Janssen Sciences Ireland Unlimited Co | Composés hétéroaromatiques ayant une activité contre vrs |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3419391A (en) * | 1965-05-24 | 1968-12-31 | Eastman Kodak Co | Silver halide color photography utilizing magenta-dye-forming couplers |
DK169672B1 (da) * | 1985-05-20 | 1995-01-09 | Mitsubishi Chem Ind | Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater |
JPH0667838B2 (ja) * | 1985-12-25 | 1994-08-31 | 三菱化成株式会社 | 過酸化脂質生成抑制剤 |
JPH01125379A (ja) * | 1987-11-10 | 1989-05-17 | Sumitomo Chem Co Ltd | 置換ピラゾール誘導体、その製造方法およびそれを有効成分とする農園芸用殺菌剤 |
WO1989010925A1 (fr) * | 1988-05-09 | 1989-11-16 | Beecham Group Plc | Nouveaux composes et traitement |
JPH03141276A (ja) * | 1989-10-24 | 1991-06-17 | Nissan Chem Ind Ltd | 置換ピラゾール誘導体および農園芸用殺菌剤 |
US5189040A (en) * | 1990-05-28 | 1993-02-23 | Sumitomo Chemical Company, Limited | Pyrazole derivatives, method for producing the same and agricultural and/or horticultural fungicides containing the same as active ingredient |
US5447831A (en) * | 1993-10-19 | 1995-09-05 | Eastman Kodak Company | Photographic element employing hue correction couplers |
US6365334B1 (en) * | 1993-10-22 | 2002-04-02 | Eastman Kodak Company | Photographic elements containing aryloxypyrazolone couplers and sulfur containing stabilizers |
GB0024795D0 (en) * | 2000-10-10 | 2000-11-22 | Hoffmann La Roche | Pyrazole derivatives for the treatment of viral diseases |
-
2003
- 2003-09-15 MX MXPA05003195A patent/MXPA05003195A/es unknown
- 2003-09-15 CA CA002497333A patent/CA2497333A1/fr not_active Abandoned
- 2003-09-15 WO PCT/IB2003/004158 patent/WO2004029042A1/fr active Application Filing
- 2003-09-15 JP JP2005501943A patent/JP2006504803A/ja not_active Withdrawn
- 2003-09-15 AU AU2003260908A patent/AU2003260908A1/en not_active Abandoned
- 2003-09-15 EP EP03798326A patent/EP1546132A1/fr not_active Withdrawn
- 2003-09-15 BR BR0314709-6A patent/BR0314709A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA05003195A (es) | 2005-06-08 |
WO2004029042A1 (fr) | 2004-04-08 |
EP1546132A1 (fr) | 2005-06-29 |
AU2003260908A1 (en) | 2004-04-19 |
BR0314709A (pt) | 2005-07-26 |
JP2006504803A (ja) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6933312B2 (en) | Pyrazole derivatives | |
CA2443449C (fr) | Derives de pyrazole pour le traitement de vih | |
EP1551828B1 (fr) | Derives de pyrazole | |
CA2497333A1 (fr) | Derives de pyrazole utilises en tant qu'inhibiteurs de la transcriptase inverse | |
US7220772B2 (en) | Pyrazole derivatives | |
EP1556381B1 (fr) | Pyrazole amides destines au traitement d'infections par le vih | |
HRP20050222A2 (en) | 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of i.a. hiv | |
US7230025B2 (en) | Pyrazole derivatives | |
EP1556359B1 (fr) | Derives de pyrazole et utilisation de ceux-ci comme agents therapeutiques destines aux maladies induites par le vih | |
US20040132793A1 (en) | Pyrazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |